Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) ("Fennec" or the "Company"), a specialty pharmaceutical company, today announced the pricing of its underwritten registered public offering of 4
(Financial Post, 2025-11-14T04:09:13Z)